AKBA Latest Press Releases

-- October 7, 2026 --

Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum Globe Newswire 8:00 AM

-- October 6, 2026 --

Akebia Therapeutics Announces Late-Breaking VOICE Trial Presentation and Posters on Akebia's Rare Kidney Pipeline at ASN Kidney Week 2026 Globe Newswire 8:00 AM

-- October 1, 2026 --

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- September 14, 2026 --

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases Globe Newswire 8:00 AM

-- September 1, 2026 --

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston Globe Newswire 8:00 AM

-- August 5, 2026 --

Akebia Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights Globe Newswire 4:05 PM

-- August 3, 2026 --

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases Globe Newswire 8:00 AM

-- July 29, 2026 --

Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights Globe Newswire 8:00 AM

-- July 2, 2026 --

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- June 30, 2026 --

U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA Globe Newswire 8:00 AM

-- June 10, 2026 --

Akebia Therapeutics Strengthens Vafseo (vadadustat) Patent Portfolio Globe Newswire 8:00 AM

-- June 1, 2026 --

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- May 28, 2026 --

Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes